About 20% of adolescents have obesity, and the numbers are expected to rise. Weight loss drugs are being considered as a tool for physicians, but there is uncertainty about their use as first-line treatments. The complications of obesity include type 2 diabetes, high blood pressure, and high cholesterol, as well as mental health issues. GLP-1 RAs like liraglutide and semaglutide are currently being studied for weight loss in children. There are concerns about the long-term side effects of these drugs. Some doctors support their use in severe cases, while others emphasize the need for more research into their risks and benefits.
Source link
Docs Worry Not Enough Known About GLP-1s and Teens
